"The U.S. Food and Drug Administration today approved Imbruvica (ibrutinib) to treat patients with mantle cell lymphoma (MCL), a rare and aggressive type of blood cancer.
MCL is a rare form of non-Hodgkin lymphoma and represents about 6 "...
Read the Patient Information that comes with BOSULIF before you start taking it and each time you get a refill. There may be new information. This leaflet does not take the place of talking with your doctor about your medical condition or treatment.
What is BOSULIF?
BOSULIF is a prescription medicine used to treat adults who have a certain type of leukemia called Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML) who no longer benefit from or did not tolerate other treatment.
It is not known if BOSULIF is safe and effective in children less than 18 years of age.
Who should not take BOSULIF?
Do not take BOSULIF if you are allergic to bosutinib or any of the ingredients in BOSULIF. See the end of this leaflet for a complete list of ingredients of BOSULIF.
What should I tell my doctor before taking BOSULIF?
Before you take BOSULIF, tell your doctor if you:
- have liver problems
- have heart problems
- have kidney problems
- have any other medical conditions
- are pregnant or plan to become pregnant. BOSULIF can harm your unborn baby. You should not become pregnant while taking BOSULIF. Tell your doctor right away if you become pregnant while taking BOSULIF.
- are a woman who may become pregnant. Use effective contraception (birth control) during and for at least 30 days after completing treatment with BOSULIF. Talk to your doctor about forms of birth control.
- are breastfeeding or plan to breastfeed. It is not known if BOSULIF passes into your breast milk or if it can harm your baby. You and your doctor should decide if you will take BOSULIF or breastfeed. You should not do both.
Tell your doctor about the medicines you take, including prescription medicines, nonprescription medicines, vitamins, and herbal supplements. BOSULIF and certain other medicines can affect each other.
Especially tell your doctor if you take:
- medicines that increase the amount of BOSULIF in your
blood stream, such as:
- amprenavir (Agenerase®)
- aprepitant (Emend®)
- atazanavir (Reyataz®)
- boceprevir (Victrelis®)
- ciprofloxacin (Cipro®, Proquin XR®)
- clarithromycin (Biaxin®, Prevpac®)
- conivaptan (Vaprisol®)
- crizotinib (Xalkori®)
- darunavir (Prezista®)
- digoxin (Lanoxin®)
- diltiazem (Cardizem®, Dilacor XR®, Tiazac®)
- erythromycin (Ery-tab®)
- fluconazole (Diflucan®)
- fosamprenavir (Lexiva®)
- imatinib (Gleevec®)
- indinavir (Crixivan®)
- itraconazole (Onmel®, Sporanox®)
- ketoconazole (Nizoral®)
- nefazodone (Serzone®)
- nelfinavir (Viracept®)
- posaconazole (Noxafil®)
- ritonavir (Kaletra®, Norvir®)
- saquinavir (Invirase®, Fortovase®)
- telaprevir (Incivek®)
- telithromycin (Ketek®)
- verapamil (Calan®, Covera-HS®, Tarka®, Verelan PM®)
- voriconazole (Vfend®)
- medicines that decrease the amount of BOSULIF in your
blood stream, such as:
- bosentan (Tracleer®)
- carbamazepine (Carbatrol®, Equetro®, Tegretol®)
- efavirenz (Sustiva®)
- etravirine (Intelence®)
- modafinil (Provigil®)
- nafcillin (Unipen®, Nallpen®)
- phenobarbital (Solfoton®)
- phenytoin (Dilantin®)
- rifabutin (Mycobutin®)
- rifampin (Rifamate®, Rifater®, Rifadin®)
- St. John's wort
BOSULIF is best absorbed from your stomach into your blood stream in the presence of stomach acid. You should avoid taking BOSULIF with medicines that reduce stomach acid, such as:
- esomeprazole (Nexium®), esomeprazole strontium
- dexlansoprazole (Dexilant®)
- lansoprazole (Prevacid®) o omeprazole (Prilosec®, Vimovo®, Zegerid®)
- pantoprazole sodium (Protonix®)
- rabeprazole (AcipHex®)
Medicines that neutralize stomach acid, such as: cimetidine (Tagamet®), famotidine (Pepcid®), ranitidine (Zantac®), aluminum hydroxide/magnesium hydroxide (Maalox®), calcium carbonate (Tums®), or calcium carbonate and magnesia (Rolaids®) may be taken up to 2 hours before or 2 hours after BOSULIF.
Know the medicines you take. Keep a list of your medicines and show it to your doctor and pharmacist when you get a new medicine.
How should I take BOSULIF?
- Take BOSULIF exactly as prescribed by your doctor.
- Do not change your dose or stop taking BOSULIF without first talking with your doctor.
- Take BOSULIF with food.
- Swallow BOSULIF tablets whole. Do not crush or cut BOSULIF tablets. Do not touch or handle crushed or broken BOSULIF tablets.
- You should avoid grapefruit, grapefruit juice, and supplements that contain grapefruit extract during treatment with BOSULIF. Grapefruit products increase the amount of BOSULIF in your body.
- Your doctor may change your dose of BOSULIF or tell you to stop taking BOSULIF depending on how you respond to treatment.
- If you miss a dose of BOSULIF, take it as soon as you remember. If you miss a dose by more than 12 hours, skip that dose and take your next dose at your regular time. Do not take two doses at the same time.
- If you take too much BOSULIF, call your doctor or go to the nearest hospital emergency room right away.
What are the possible side effects of BOSULIF?
BOSULIF may cause serious side effects, including:
- Stomach problems. BOSULIF may cause stomach (abdomen) pain, nausea, diarrhea, or vomiting. Tell your doctor about any stomach problems.
- Low blood cell counts. BOSULIF may cause low platelet counts (thrombocytopenia), low red blood cell counts (anemia) and low white blood cell counts (neutropenia). Your doctor should do blood tests to check your blood cell counts regularly during your treatment with BOSULIF. Call your doctor right away if you have unexpected bleeding or bruising, blood in your urine or stools, fever, or any signs of an infection.
- Liver problems. BOSULIF may cause liver problems. Your doctor should do blood tests to check your liver function regularly during your treatment with BOSULIF. Call your doctor right away if your skin or the white part of your eyes turns yellow (jaundice) or you have dark “tea color” urine.
- Your body may hold too much fluid (fluid retention). Fluid
may build up in the lining of your lungs, the sac around your heart, or your
stomach cavity. Call your doctor right away if you get any of the following
symptoms during your treatment with BOSULIF:
- shortness of breath and cough
- chest pain
- swelling in your hands, ankles, or feet
- swelling all over your body
- weight gain
- The other common side effects of BOSULIF include:
- tiredness or weakness
Tell your doctor right away if you get respiratory tract infections, loss of appetite, headache, dizziness, back pain, joint pain, or itching while taking BOSULIF. These may be symptoms of a severe allergic reaction.
Tell your doctor if you have any side effect that bothers you or that does not go away.
These are not all of the possible side effects of BOSULIF. For more information, ask your doctor or pharmacist.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
How do I store BOSULIF?
- Store BOSULIF between 68°F to 77°F (20°C to 25°C).
- Ask your doctor or pharmacist about the right way to throw away outdated or unused BOSULIF.
Keep BOSULIF and all medicines out of the reach of children.
General information about BOSULIF:
Medicines are sometimes prescribed for purposes other than those listed in the Patient Information leaflet. Do not use BOSULIF for a condition for which it is not prescribed. Do not give BOSULIF to other people even if they have the same symptoms you have. It may harm them.
This Patient Information leaflet summarizes the most important information about BOSULIF. If you would like more information, talk with your doctor. You may ask your doctor or pharmacist for information about BOSULIF that is written for healthcare professionals.
For more information, go to www.Bosulif.com or www.pfizermedicalinformation.com or call 1-800-438-1985.
What are the ingredients in BOSULIF?
Active ingredient: bosutinib.
Inactive ingredients: microcrystalline cellulose, croscarmellose sodium, poloxamer, povidone, magnesium stearate, polyvinyl alcohol, titanium dioxide, polyethylene glycol, talc, and iron oxide yellow (for 100 mg tablet) and iron oxide red (for 500 mg tablet).
This Patient Information has been approved by the U.S. Food and Drug Administration.
Last reviewed on RxList: 10/17/2013
This monograph has been modified to include the generic and brand name in many instances.
Additional Bosulif Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.